Immunostimulatory sequence oligodeoxynucleotide: A novel mucosal adjuvant

Clinical Immunology

Volumn 95, Issue 1 II, 2000, Pages

  Horner, Anthony A ^a   Raz, Eyal ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adjuvants; CpG motifs; Immunostimulatory sequence oligonucleotides; Mucosal immunity

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; OLIGODEOXYNUCLEOTIDE;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; KNOCKOUT MOUSE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; VACCINATION;

EID: 0034116281     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4815     Document Type: Conference Paper

References (46)

1. Czerkinsky, C., and Holmgren, J., The mucosal immune system and prospects for anti-infectious and anti-inflammatory vaccines. Immunologist 3, 97-103, 1995.
2. Staats, H. F., and McGhee, J. R., Application of basic principles of mucosal immunity to vaccine development. In "Mucosal Vaccines" (H. Kiyono, P. L. Ogra, and J. R. McGhee, Eds.), pp. 15-40, Academic Press, San Diego, 1996.
3. Ada, G. L., and McElrath, M. J., HIV type 1 vaccine induced cytotoxic T cell responses: Potential role in vaccine efficacy. AIDS Res. Hum. Retroviruses 13, 205-210, 1997.
4. Gallichan, W. S., Johnson, D. C., Graham, F. L., and Rosenthal, K. L., Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein. J. Infect. Dis. 168, 622-629, 1993.
5. Gutpa, R. K., and Siber, G. R., Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13, 1263-1276, 1995.
6. Marinaro, M., Staats, H. F., Hiroi, T., Jackson, R. J., Coste, M., Boyaka, P. N., Okahashi, N., Yamamoto, M., Kiyono, H., Bluethmann, H., Fujihashi, K., and McGhee, J. R., Mucosal adjuvant effect of cholera toxin in mice results in the production of T helper 2 (Th2) cells and IL-4. J. Immunol. 155, 4621-4629, 1995.
7. Snider, D. P., Marshal, J. S., Perdue, M. H., and Liang, H., Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein antigen and cholera toxin. J. Immunol. 153, 647-657, 1994.
8. Davis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L., Schorr, J., and Krieg, A. M., CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160, 870-876, 1998.
9. Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M. D., Sato, Y., Ronaghy, A., Kornbluth, R., Richman, D. D., Carson, D. A., and Raz, E., Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Med. 3, 849-854, 1997.
10. Sato,Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M. D., Silverman, G. J., Lotz, M., Carson, D. A., and Raz, E., Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352-354, 1996.
11. Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Rocken, M., Wagner, H., and Heeg, K., CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 160, 3627-3630, 1998.
12. Horner, A. A., Ronaghy, A., Cheng, P. M., Nguyen, M. D., Cho, H. J., Broide, D., and Raz, E., Immunostimulatory DNA is a potent mucosal adjuvant. Cell. Immunol. 190, 77-82. 1998.
13. Klinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J., and Krieg, A. M., CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon-γ. Proc. Natl. Acad. Sci. USA 93, 2879-2883, 1996.
14. Pisetsky, D. S., Immune activation by bacterial DNA: A new genetic code. Immunity 5, 303-310, 1996.
15. Yamamoto, S., Yamimoto, T., Kataoka, T., Kuramoto, E., Yano, O., and Tokunaga, T., Unique palindromic sequences in synthetic nucleotides required to induce IFN and augment IFN-mediated natural killer cell activity. J. Immunol. 148, 4072-4076, 1992.
16. Coffman, R. L., and Mosmann, T. R., Isotype regulation by helper T cells and lymphokines. Monogr. Allergy 24, 96-103. 1988.
17. 2 cells: Differential patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173, 1989.
18. Anitescu, M., Chace, J. H., Tuetken, R., Yi, A. K., Berg, D. J., Krieg, A. M., and Cowdery, J. S., Interleukin-10 functions in vitro and in vivo to inhibit bacterial DNA induced secretion of interleukin-12. J. Interferon Cytokine Res. 17, 781-788, 1997.
19. Defrance, T., Vanbervliet, B., Briere, F., Durand, I., Rousett, F., and Banchereau, J., Interleukin-10 and transforming growth factor β cooperate to induce anti-CD40 -activated naïve human B cells to secrete immunoglobulin A. J. Exp. Med. 175, 671-682, 1992.
20. Muraguchi, A., Hirano, T., Tang, B., Matsuda, T., Horii, Y., Nakajima, K., and Kishimoto, T., The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J. Exp. Med. 167, 332-344, 1988.
21. Boyaka, P. N., Marinaro, M., Jackson, R. J., Menson S., Kiyono, H., Jirillo, E., and McGhee, J. R., IL-12 is an effective adjuvant for the induction of mucosal immunity. J. Immunol. 162, 122-128, 1999.
22. Jakob, T., Walker, P. S., Krieg, A. M., Udey, M. C., and Vogel, J. C., Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dentritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161, 3042-3049, 1998.
23. Martin-Orozco, E., Kobayashi, H., Van Uden, J., Nguyen, M. D., Kornbluth, R. S., and Raz, E., Enhancement of antigen presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences Int. Immunol. 7, 1111-1118, 1999.
24. Shahinian, A., Pfeffer, K., Lee, K. P., Kundig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., and Mak, T. W., Differential T cell costimulatory requirements in CD28-deficient mice. Science 261, 609-612, 1993.
25. Sparwasser, T., Koch, E. S., Vabulas, R. M., Heeg, K., Lipford, G. B., Ellwart, J. W., and Wagner, H., Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28, 2045-2054, 1998.
26. Fuleihan, R., Ramesh, N., Loh, R., Jabara, H., Rosen, F. S., Chatila, T., Fu, S. M., Stamenkovic, I., and Geha, R. S., Defective expression of the CD40 ligand in x chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA 90, 2170-2173, 1993.
27. Karlsson, L., Castano, A. R., and Peterson, P. A., Principles of antigen processing and presentation. In "Essentials of Mucosal Immunology" (M. F. Kagnoff and H. Kiyono, Eds.), pp. 3-28, Academic Press, San Diego, 1996.
28. Kline, J. N., Waldschmidt, T. J., Businga, T. R., Lemish, J. E., Weinstock, J. V., Thorne, P. S., and Krieg, A. M., Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160, 2555-2559, 1998.
29. Broide, D., Schwarze, J., Tighe, H., Gifford, T., Nguyen, M. D., Malekk, S., Van Uden, J., Martain-Orozco, E., Gelfand, E. W., and Raz, E., Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J. Immunol. 161, 7054-7062, 1998.
30. Weiner, G. J., Liu, H. M., Wooldridge J. E., Dahle, C. E., and Krieg, A. M., Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl. Acad. Sci. USA 94, 10833-10837, 1997.
31. Oxenius, A., Martinic, M. M., Hengartner, H., and Klenerman, P., CpG-containing oligonucleotides are efficient adjuvants for induction of prootective antiviral immune responses with T-cell peptide vaccines. J. Virol. 73, 4120-4126, 1999.
32. Walker, P. S., Scharton-Kersten, T., Krieg, A. M., Love-Homan, L., Rowton, E. D., Udey, M. C., and Vogel, J. C., Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12 and IFN-gamma-dependent mechanisms. Proc. Natl. Acad. Sci. USA 96, 6970-6975, 1999.
33. Elkins, K. L., Rhinehart-Jones, T. R., Stibitz, S., Conover, J. S., and Klinman, D. M., Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162, 2291-2298, 1999.
34. Berlin, C., Berg, E. L., Briskin, M. J., Andrew, D. P., Kilshaw, P. J., Holzmann, B., Weissman, I. L., Hamann, A., and Butcher, E. C., α4β7 Integrin mediates lymphocyte binding to the mucosal vascular adressin MAdCAM-1. Cell 74, 185-195, 1993.
35. Quiding-Jarbrink, M., Nordstrom, I., Granstrom, G., Kilander, A., Jertborn, M., Butcher, E. C., Lazarovits, A. I., Holmgren, J., and Czerkinsky, C., Differential expression of tissue-specific adhesion molicules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. J. Clin. Invest. 99, 1281-1286, 1997.
36. McCluskie, M. J., and Davis, H. L., CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration in mice. J. Immunol. 161, 4463-4466, 1998.
37. Carpenter, E. A., Rudy, J., and Ramshaw, I. A., IFN-gamma, TNF, and IL-6 production by vaccina virus immune spleen cells: An in vitro study. J. Immunol. 152, 2652-2659, 1994.
38. 2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect. Immun. 64, 1516-1525, 1996.
39. Moldoveanu, Z., Love-Homan, L., Huang, W. Q., and Kreig, A. M., CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16, 1216-1221, 1998.
40. Smith, C. B., Influenza viruses. In "Infectious Diseases" (S. L. Gornbach, J. G. Bartlett, and N. R. Blacklow, Eds.), pp. 2120-2125, Saunders, Philadelphia, 1998.
41. Marinaro, M., Boyaka, P. N., Finkelman, F. D., Kiyono, H., Jackson, R. J., Jirillo, E., and McGhee, J. R., Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J. Exp. Med. 185, 415-427, 1997.
42. Assenmacher, M., Schmitz, J., and Radbruch, A., Flow cytometric determination of cytokines in activated murine T helper lymphocytes: Expression of interleukin-10 in interferon-gamma and in interleukin-4 producing cells. Eur. J. Immunol. 24, 1097-1101, 1994.
43. Letvin, N. L., Progress in the development of an HIV-1 vaccine. Science 280, 1875-1880, 1998.
44. VanCott, T. C., Kaminski, R. W., Mascola, J. R., Kalyanaraman, V. S., Wassef, N. M., Alving, C. R., Ulrich, J. T., Lowell, G. H., and Birx, D. R., HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp120. J. Immunol. 160, 2000-2012, 1998.
45. Webb, A., Cunningham, D., Cotter, F., Clarke, P. A., di Stefano, F., Ross, P., Corbo, M., and Dziewanowska, Z., BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet 349, 1137-1141, 1997.
46. Ballas, Z. K., Rasmussen, W. L., and Krieg, A. M., Induction of natural killer cell activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157, 1840-1845, 1996.